| مستخلص: |
It had been evident that non‐alcoholic fatty liver disease (NAFLD) is the new era epidemic. Despite emergence of many drugs on the pipeline that considered candidates to cure NAFLD/NASH, the critical need for defining the cohort liable to fibrosis progression is yet unmet. Evaluate ABCA1 (rs1800977) genotyping as a noninvasive predictor of liver fibrosis severity. This study included 118 liver biopsy‐proven NAFLD‐patients. According to Metavir‐fibrosis‐staging, cases were divided to early fibrosis (74 cases), and 44 cases with significant fibrosis (>F2), added to 49 healthy control subjects. All patients were subjected to liver function tests, lipids profile, triglyceride TG index, and hepatic steatosis index (HSI) and real‐time PCR ABCA1 SNP (rs1800977). Significant differences in transaminases (p> .05), albumin (p< .009), cholesterol (p0.03), low density lipoproteins (LDL) (0.006), triglycerides (p< .001), HSI (p< .001), FIB4 (p< .001) and APRI (p< .001) were reported in those with significant than early fibrosis and control groups. CC was the most prevalent in significant (36.4%) than early fibrosis (13.5%) and control groups (8.2%), with prevalence of C allele in significant fibrosis (p≤ .003). Univariate analysis revealed that DM (p≤ .001), TG index (p≤ .022), cholesterol (p≤ .03), HSI (p≤ .006), LDL (p≤ .02), HDL (p≤ .01), APRI (p≤ .02) and CC genotype (p≤ .005) were the main factors affecting fibrosis progression in NAFLD. However multivariate analysis proved only the role of HSI (p≤ .005), LDL (p≤ .02), HDL (p≤ .003) and CC genotype (p≤ .03) in predicting fibrosis severity. Dyslipidemias, hepatic steatosis index and ABCA1 (rs1800977) gene polymorphism CC genotype; were the only independent predictors of advanced fibrosis in NAFLD‐patients. Dyslipidemias, hepatic steatosis index, and ABCA1 (rs1800977) gene polymorphism CC genotype; were the only independent predictors of advanced fibrosis in NAFLD‐patients. |
Full Text Finder